Avantor (NYSE:AVTR) Director Gregory Summe Purchases 100,000 Shares

Avantor, Inc. (NYSE:AVTR) Director Gregory Summe bought 100,000 shares of the stock in a transaction on Thursday, February 12th. The stock was purchased at an average price of $9.40 per share, with a total value of $940,000.00. Following the completion of the purchase, the director owned 400,000 shares of the company’s stock, valued at $3,760,000. This represents a 33.33% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link.

Avantor Stock Down 5.2%

Shares of AVTR traded down $0.50 during midday trading on Thursday, hitting $9.14. 20,856,423 shares of the company’s stock traded hands, compared to its average volume of 13,996,063. The company has a current ratio of 1.49, a quick ratio of 0.96 and a debt-to-equity ratio of 0.65. The stock has a market capitalization of $6.23 billion, a price-to-earnings ratio of -70.31, a price-to-earnings-growth ratio of 3.87 and a beta of 0.94. Avantor, Inc. has a 1 year low of $8.90 and a 1 year high of $18.36. The firm’s fifty day moving average is $11.46 and its 200-day moving average is $12.28.

Avantor (NYSE:AVTR) last issued its quarterly earnings results on Wednesday, February 11th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.21 by $0.01. Avantor had a positive return on equity of 10.91% and a negative net margin of 1.25%.The business had revenue of $1.66 billion during the quarter, compared to the consensus estimate of $1.64 billion. During the same quarter last year, the company earned $0.27 earnings per share. The company’s quarterly revenue was down 1.4% on a year-over-year basis. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. As a group, sell-side analysts anticipate that Avantor, Inc. will post 1.06 earnings per share for the current year.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. TD Private Client Wealth LLC grew its stake in Avantor by 9.2% during the 3rd quarter. TD Private Client Wealth LLC now owns 7,985 shares of the company’s stock valued at $100,000 after acquiring an additional 670 shares in the last quarter. Private Trust Co. NA boosted its holdings in shares of Avantor by 46.2% during the 4th quarter. Private Trust Co. NA now owns 2,769 shares of the company’s stock worth $32,000 after purchasing an additional 875 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Avantor by 28.1% in the third quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,123 shares of the company’s stock valued at $49,000 after purchasing an additional 905 shares in the last quarter. Truist Financial Corp increased its holdings in shares of Avantor by 2.2% in the second quarter. Truist Financial Corp now owns 44,325 shares of the company’s stock valued at $597,000 after purchasing an additional 959 shares during the last quarter. Finally, TD Waterhouse Canada Inc. lifted its position in Avantor by 2.5% during the third quarter. TD Waterhouse Canada Inc. now owns 38,977 shares of the company’s stock worth $532,000 after buying an additional 966 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Analyst Ratings Changes

AVTR has been the subject of several research analyst reports. Robert W. Baird set a $11.00 price objective on Avantor in a research note on Thursday. Raymond James Financial lowered shares of Avantor from an “outperform” rating to a “market perform” rating in a research report on Tuesday, November 4th. Barclays decreased their price objective on shares of Avantor from $12.00 to $9.00 and set an “equal weight” rating for the company in a research note on Thursday. Jefferies Financial Group reiterated an “underperform” rating and issued a $8.00 price objective on shares of Avantor in a research note on Thursday. Finally, Evercore ISI set a $10.00 target price on shares of Avantor in a report on Wednesday. Three equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Avantor has an average rating of “Hold” and a consensus target price of $12.09.

Trending Headlines about Avantor

Here are the key news stories impacting Avantor this week:

• Positive Sentiment: Q4 adjusted EPS topped consensus and the company delivered positive operating and free cash flow, providing some fundamental support despite topline pressures. Avantor, Inc. (AVTR) Surpasses Q4 Earnings and Revenue Estimates
• Positive Sentiment: Full-year results show meaningful adjusted EBITDA and solid operating/free cash flow (helpful for deleveraging and funding the turnaround initiatives). Avantor® Reports Fourth Quarter and Full Year 2025 Results
• Neutral Sentiment: Management outlined a strategic “revival” program (VWR relaunch, supply-chain and e-commerce upgrades) intended to stabilize growth — potential long-term benefit but execution risk remains. AVTR Q4 Deep Dive: Strategic Overhaul and Market Transition Shape 2026 Outlook
• Neutral Sentiment: Full earnings-call and slide materials are available for investors to check management’s cadence on cost savings and margin recovery — useful for assessing whether guidance is credible. Avantor, Inc. (AVTR) Q4 2025 Earnings Call Transcript
• Negative Sentiment: FY2026 EPS guidance (0.77–0.83) came in below the ~0.90 consensus, signaling more near-term pressure on margins and growth and triggering downside re-rating. (Guidance announced 2/11/2026.)
• Negative Sentiment: Revenue declined year-over-year and margins contracted in Q4; the company posted a FY2025 GAAP net loss, reinforcing investor concern over the near-term profitability profile. AVTR Stock Plunges Despite Q4 Earnings Beat Estimates, Margins Decline
• Negative Sentiment: Unusually large put-option activity (massive buy of puts) indicates elevated bearish positioning and may amplify downside volatility as traders hedge or speculate. (Options flow reported 2/11/2026.)

Avantor Company Profile

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.